Validation of sham treatment in hyperbaric medicine: a randomised trial.

Blinding Hyperbaric research Placebo Research methods

Journal

Diving and hyperbaric medicine
ISSN: 1833-3516
Titre abrégé: Diving Hyperb Med
Pays: Australia
ID NLM: 101282742

Informations de publication

Date de publication:
31 Mar 2023
Historique:
received: 27 07 2022
accepted: 10 01 2023
pmc-release: 31 03 2024
medline: 28 3 2023
entrez: 26 3 2023
pubmed: 27 3 2023
Statut: ppublish

Résumé

This study aimed to determine the lowest possible atmospheric pressure in the 111-152 kPa (1.1-1.5 atmospheres absolute [atm abs]) range that would require the patients to equalise their ears, allowing an effective sham for a 203 kPa (2.0 atm abs) hyperbaric exposure. We performed a randomised controlled study on 60 volunteers divided into 3 groups (compression to 111, 132 and 152 kPa (1.1, 1.3, 1.5 atm abs) to determine the minimum pressure to obtain blinding. Secondly, we applied additional blinding strategies (faster compression with ventilation during the fictitious compression time, heating at compression, cooling at decompression) on 25 new volunteers in order to enhance blinding. The number of participants who did not believe they had been compressed to 203 kPa was significantly higher in the 111 kPa compressed arm than in the other two arms (11/18 vs 5/19 and 4/18 respectively; P = 0.049 and P = 0.041, Fisher's exact test). There was no difference between compressions to 132 and 152 kPa. By applying additional blinding strategies, the number of participants who believed they had been compressed to 203 kPa increased to 86.5 %. A compression to 132 kPa, (1.3 atm abs, 3 metres of seawater equivalent) combined with the additional blinding strategies of forced ventilation, enclosure heating and compression in five minutes, simulates a therapeutic compression table and can be used as a hyperbaric placebo.

Identifiants

pubmed: 36966522
doi: 10.28920/dhm53.1.51-54
pmc: PMC10318180
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-54

Informations de copyright

Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Références

Clin Trials. 2018 Oct;15(5):462-476
pubmed: 29865904

Auteurs

Pierre Louge (P)

Diving and hyperbaric Unit, University hospitals of Geneva, Geneva, Switzerland.
Corresponding author: Dr Pierre Louge, Diving and hyperbaric Unit, University hospitals of Geneva, Geneva, Switzerland, pierre.louge@hcuge.ch.

Rodrigue Pignel (R)

Diving and hyperbaric Unit, University hospitals of Geneva, Geneva, Switzerland.

Jacques Serratrice (J)

Department of medicine, General Internal Medicine Service, University hospitals of Geneva, Geneva, Switzerland.

Jerome Stirnemann (J)

Department of medicine, General Internal Medicine Service, University hospitals of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH